Article Details
Retrieved on: 2022-12-08 17:10:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The regulator added that data supporting use of Pfizer/BioNTech's bivalent shot as a booster in this age group is expected in January.
Article found on: www.devdiscourse.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here